Exane Derivatives’s Celsius Holdings CELH Stock Holding History

Exane Derivatives’s Portfolio CELH Stock Details CELH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$261	Sell	12 -8,448	-100%	-$163K	﹤0.01%	648
2022 Q1	$156K	Sell	8,460 -2,169	-20%	-$38.9K	0.04%	393
2021 Q4	$264K	Sell	10,629 -3,195	-23%	-$88.4K	0.06%	288
2021 Q3	$415K	Sell	13,824 -2,280	-14%	-$58.6K	0.1%	218
2021 Q2	$385K	Sell	16,104 -5,154	-24%	-$105K	0.09%	237
2021 Q1	$340K	Sell	21,258 -8,424	-28%	-$158K	0.1%	200
2020 Q4	$498K	Buy	+29,682	New	+$296K	0.15%	156

Other funds holding CELH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Exane Derivatives's CELH Position: Q2 2022 in Review

Exane Derivatives reduced its Celsius Holdings (CELH) stake by 100% in Q2 2022, selling an estimated $163K and leaving 12 shares worth $261. The position accounts for ﹤0.01% of the portfolio, ranked #648.

Exane Derivatives first reported a position in CELH in Q4 2020 and has held it in 7 quarters since. The position peaked at $498K in Q4 2020. 251 funds tracked by Wall St. Rank hold CELH as of Q2 2022.

Exane Derivatives held 12 shares of Celsius Holdings worth $261 as of Q2 2022.
Exane Derivatives sold 8,448 Celsius Holdings shares in Q2 2022, an estimated $163K.
Celsius Holdings made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #648 holding.
Exane Derivatives first reported a position in Celsius Holdings in Q4 2020 and has held it in 7 quarters since.
Exane Derivatives's Celsius Holdings position peaked at $498K in Q4 2020.
251 funds tracked by Wall St. Rank held Celsius Holdings as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.